Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients’ lives and provide an attractive return on investment.
Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.
Karolinska Development has established a portfolio of 10 companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.
The Company is led by a team including investment professionals with strong venture capital backgrounds, experienced company builders and entrepreneurs, with access to a strong global network.
For more information, please visit www.karolinskadevelopment.com
Company Details
- Employees
- 26
- Founded
- -
- Address
- Nanna Svartz Väg 6a, Solna,stockholm County 17165,sweden
- Phone
- +46 72 858 32 09
- in****@****ent.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- karolinskadevelopment.com
- HQ
- Solna, Stockholm County
Karolinska Development Questions
Karolinska Development's helpline number is +46 72 858 32 09
Karolinska Development's website is karolinskadevelopment.com
Karolinska Development's LinkedIn profile is https://se.linkedin.com/company/karolinska-development
Karolinska Development has
26 employees.
View email and phone details for 26
employees at Karolinska Development.
Karolinska Development's industry is
Venture Capital and Private Equity Principals
Karolinska Development's top competitors are
Empe Diagnostics,
Promimic,
Neogap Therapeutics Ab,
Eleva,
Umecrine Cognition Ab,
Phion Therapeutics,
Sciety,
Capitainer,
Invox,
Pharmnovo.
Karolinska Development's support email address is info@karolinskadevelopment.com
Karolinska Development's categories are Venture Capital and Private Equity Principals
Karolinska Development's founding year is 2003
